International Patent: FUSION PROTEIN FOR PREVENTING PLASMODIUM INFECTION, IMMUNOGENIC COMPOSITION, AND USE

GENEVA, Aug. 31 -- NANJING CHENGSHI BIOMEDICAL TECHNOLOGY CO., LTD. filed a patent application (CN2026/079692) for “FUSION PROTEIN FOR PREVENTING PLASMODIUM INFECTION, IMMUNOGENIC COMPOSITION, AND USE”. With publication no. WO/2026/175406, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 19/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....